Latest In

Breaking News

Japan Renaming Dementia into Cognitive Disorder

The Ministry of Health, Labour and Welfare of Japan formally proposed a report to rename "dementia" to "cognitive disorder". The report believes that terms such as "dementia" will cause significant harm to related patients, particularly elderly patients, and will give people the wrong impression that "these patients don't know anything" which causes a sense of horror and shame.

Author:Karan Emery
Reviewer:Stefano Mclaughlin
Jan 13, 2021
44.8K Shares
1M Views
Japan's Ministry of Health, Labor and Welfare officially submitted a report to rename "dementia" to "cognitive disorder". The study believes that terms such as "dementia" will cause significant harm to associated patients, particularly elderly patients, and will give people the wrong idea that "these patients don't know anything" which causes a feeling of horror and shame. The sensation has caused obstacles to the discovery and treatment of the disease.
According to statistics from the Ministry of Health and Welfare, there are currently 1.5 million patients with "dementia" in Japan, and the opinion that other words should be used instead of "dementia" has also appeared in Japan for several years.
In June 2004, the Ministry of Health, Welfare and Welfare formed a study group to replace the word "dementia" Experts agree that the so-called "dementia" is simply a deterioration in the thinking and physical ability of average people. It is not fitting to call this name, and there is a temptation to use the term "dementia" indiscriminately.
The research committee began collecting opinions across the country in September 2004. The final results of the solicitation of opinions according to the number of votes are: "Memory Disorder", "Dementia", "Amnesia", " memory disorder", etc. "Cognitive disorder" has been used in psychiatry, so replacing "dementia" with "cognitive disorder" may cause confusion. Therefore, the research committee finally decided to replace "dementia" with "cognitive disorder" ".
Karan Emery

Karan Emery

Author
Karan Emery, an accomplished researcher and leader in health sciences, biotechnology, and pharmaceuticals, brings over two decades of experience to the table. Holding a Ph.D. in Pharmaceutical Sciences from Stanford University, Karan's credentials underscore her authority in the field. With a track record of groundbreaking research and numerous peer-reviewed publications in prestigious journals, Karan's expertise is widely recognized in the scientific community. Her writing style is characterized by its clarity and meticulous attention to detail, making complex scientific concepts accessible to a broad audience. Apart from her professional endeavors, Karan enjoys cooking, learning about different cultures and languages, watching documentaries, and visiting historical landmarks. Committed to advancing knowledge and improving health outcomes, Karan Emery continues to make significant contributions to the fields of health, biotechnology, and pharmaceuticals.
Stefano Mclaughlin

Stefano Mclaughlin

Reviewer
Stefano Mclaughlin is a Psychologist focused on mental health, emotional well-being, and healthcare policy. He studied Psychology and Public Health at the University of Massachusetts Amherst, gaining a deep understanding of the intersection between mental health and public policy. Stefano's mission is clear: he aims to destigmatize mental health discussions, improve access to mental healthcare, and promote emotional well-being for all. Drawing from personal experiences with anxiety and depression, Stefano shares real stories to make mental health topics more relatable and less intimidating. In addition to his advocacy work, Stefano enjoys delving into books, experimenting in the kitchen, and embarking on new adventures. These hobbies fuel his creativity and inspire fresh perspectives for his advocacy work.
Latest Articles
Popular Articles